Mettler-Toledo International, Inc. (NYSE:MTD) Shares Sold by Beacon Investment Advisory Services Inc.

Beacon Investment Advisory Services Inc. decreased its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 14.8% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 21,080 shares of the medical instruments supplier's stock after selling 3,676 shares during the period. Beacon Investment Advisory Services Inc. owned 0.10% of Mettler-Toledo International worth $24,894,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Edmond DE Rothschild Holding S.A. purchased a new stake in Mettler-Toledo International in the 4th quarter valued at about $44,000. Golden State Wealth Management LLC raised its stake in shares of Mettler-Toledo International by 583.3% in the 1st quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock valued at $48,000 after acquiring an additional 35 shares during the period. Menard Financial Group LLC acquired a new position in shares of Mettler-Toledo International in the 4th quarter worth approximately $67,000. Blue Trust Inc. lifted its holdings in shares of Mettler-Toledo International by 520.0% in the 1st quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after acquiring an additional 52 shares during the last quarter. Finally, Farther Finance Advisors LLC boosted its position in shares of Mettler-Toledo International by 39.1% during the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock worth $103,000 after purchasing an additional 25 shares during the period. Institutional investors and hedge funds own 95.07% of the company's stock.

Insiders Place Their Bets

In related news, Director Michael A. Kelly sold 1,062 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the completion of the transaction, the director directly owned 120 shares of the company's stock, valued at $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Stock Performance

Shares of NYSE:MTD traded up $5.33 during trading hours on Thursday, reaching $1,262.53. The stock had a trading volume of 196,872 shares, compared to its average volume of 134,707. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,546.93. The firm's 50 day moving average is $1,179.25 and its 200-day moving average is $1,193.87. The stock has a market capitalization of $26.24 billion, a price-to-earnings ratio of 31.48, a P/E/G ratio of 3.86 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 EPS for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The firm had revenue of $883.74 million for the quarter, compared to analyst estimates of $876.61 million. During the same quarter in the prior year, the company posted $8.89 earnings per share. Mettler-Toledo International's revenue for the quarter was down 4.6% compared to the same quarter last year. Analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Analysts Set New Price Targets

MTD has been the topic of a number of research reports. Evercore ISI upped their price target on Mettler-Toledo International from $1,200.00 to $1,280.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 8th. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their target price for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Citigroup upgraded shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a research note on Monday, April 7th. Wall Street Zen lowered shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Finally, Barclays began coverage on shares of Mettler-Toledo International in a report on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective for the company. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $1,280.90.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.